Interactions between octaarginine and U-937 human macrophages: Global gene expression profiling, superoxide anion content, and cytokine production

Journal of Controlled Release

Volumn 139, Issue 3, 2009, Pages 197-204

  Kuo, Jung hua Steven ^a   Jan, Ming shiou ^b   Lin, Yi Lin ^a   Lin, Clay ^c  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c Welgene Biotech Co Ltd   (Taiwan)

Author keywords

Cell penetrating peptides; Cytokines; Macrophage; Microarray; Octaarginine; Superoxide anion

Indexed keywords

ACTIVE MEMBRANES; CELL LINES; CELL PENETRATING PEPTIDES; CELL-PENETRATING PEPTIDE; CONCENTRATION-DEPENDENT; CYTOKINE PRODUCTION; CYTOKINES; GENE EXPRESSION PROFILING; GENOME-WIDE PROFILING; HUMAN MACROPHAGES; IMMUNE FUNCTION; IMMUNE RESPONSE; INTRACELLULAR DELIVERY; KINETIC ANALYSIS; MICROARRAY ANALYSIS; OCTAARGININE; PROINFLAMMATORY CYTOKINES; REVERSE TRANSCRIPTASE- POLYMERASE CHAIN REACTION; SUPEROXIDE ANION; SUPEROXIDE ANIONS; TIME POINTS;

AMINES; BIOACTIVITY; CELL CULTURE; CYTOTOXICITY; GENE EXPRESSION; IONS; MACROPHAGES; OXYGEN; PEPTIDES;

CELL MEMBRANES;

CELL PENETRATING PEPTIDE; COMPLEMENT COMPONENT C1R; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1BETA; INTERLEUKIN 6; OCTAARGININE; ONCOSTATIN M; PROTEIN FOS; SUPEROXIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BINDING KINETICS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTERNALIZATION; MACROPHAGE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

BIOLOGICAL TRANSPORT; CLUSTER ANALYSIS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; KINETICS; MACROPHAGE ACTIVATION; MACROPHAGES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGOPEPTIDES; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDES; U937 CELLS;

EID: 70349431107     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.07.006     Document Type: Article

References (25)

1. Mae M., and Langel U. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr. Opin. Pharmacol. 6 (2006) 509-514
2. Vives E. Present and future of cell-penetrating peptide mediated delivery systems: "is the Trojan horse too wild to go only to Troy?". J. Control. Release 109 (2005) 77-85
3. Gupta B., Levchenko T.S., and Torchilin V.P. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv. Drug Deliv. Rev. 57 (2005) 637-651
4. Wu R.P., Youngblood D.S., Hassinger J.N., Lovejoy C.E., Nelson M.H., Iversen P.L., and Moulton H.M. Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity. Nucleic Acids Res. 35 (2007) 5182-5191
5. El-Andaloussi S., Jarver P., Johansson H.J., and Langel U. Cargo dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study. Biochem. J. 407 (2007) 285-292
6. Cardozo A.K., Buchillier V., Mathieu M., Chen J., Ortis F., Ladriere L., Allaman-Pillet N., Poirot O., Kellenberger S., Beckmann J.S., Eizirik D.L., Bonny C., and Maurer F. Cell-permeable peptides induce dose- and length-dependent cytotoxic effects. Biochim. Biophys. Acta 1768 (2007) 2222-2234
7. Patel L.N., Zaro J.L., and Shen W.C. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm. Res. 24 (2007) 1977-1992
8. Futaki S. Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms. Biopolymers 84 (2006) 241-249
9. Futaki S. Membrane-permeable arginine-rich peptides and the translocation mechanisms. Adv. Drug Deliv. Rev. 57 (2005) 547-558
10. Maiolo J.R., Ferrer M., and Ottinger E.A. Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. Biochim. Biophys. Acta 1712 (2005) 161-172
11. Nakase I., Tadokoro A., Kawabata N., Takeuchi T., Katoh H., Hiramoto K., Negishi M., Nomizu M., Sugiura Y., and Futaki S. Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. Biochemistry 46 (2007) 492-501
12. Tréhin R., and Merkle H.P. Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur. J. Pharm. Biopharm. 58 (2004) 209-233
13. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., and Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276 (2001) 5836-5840
14. Iles K.E., and Forman H.J. Macrophage signaling and respiratory burst. Immunol. Res. 26 (2002) 95-105
15. Rothe G., and Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescin. J. Leukoc. Biol. 47 (1990) 440-448
16. Bally I., Rossi V., Thielens N.M., Gaboriaud C., and Arlaud G.J. Functional role of the linker between the complement control protein modules of complement protease C1s. J. Immunol. 175 (2005) 4536-4542
17. Tanaka M., Miyajima A., and Oncostatin M. A multifunctional cytokine. Rev. Physiol. Biochem. Pharmacol. 149 (2003) 39-52
18. Grenier A., Dehoux M., Boutten A., Arce-Vicioso M., Durand G., Gougerot-pocidalo M.A., and Chollet-Martin S. Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood 93 (1999) 1413-1421
19. Subramaniam S., Stansberg C., and Cunningham C. The interleukin 1 receptor family. Dev. Comp. Immunol. 28 (2004) 415-428
20. Acquaviva C., Bossis G., Ferrara P., Brockly F., Jariel-Encontre I., and Piechaczyk M. Evasion from proteasomal degradation by mutated Fos proteins expressed from FBJ-MSV and FBR-MSV osteosarcomatogenic retroviruses. Biochem. Pharmacol. 64 (2002) 957-961
21. Piechaczyk M., and Blanchard J.M. c-fos proto-oncogene regulation and function. Crit. Rev. Oncol. Hematol. 17 (1994) 93-131
22. Clark I.A. How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 18 (2007) 335-343
23. Toussirot E., and Wendling D. The use of TNF-alpha blocking agents in rheumatoid arthritis: an update. Expert Opin. Pharmacother. 8 (2007) 2089-2107
24. Fotin-Mleczek M., Welte S., Mader O., Duchardt F., Fischer R., Hufnagel H., Scheurich P., and Brock R. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization. J. Cell Sci. 118 (2005) 3339-3351
25. Ginsburg I. Cationic polyelectrolytes: a new look at their possible roles as opsonins, as stimulators of respiratory burst in leukocytes, in bacteriolysis, and as modulators of immune-complex diseases (a review hypothesis). Inflammation 11 (1987) 489-515